신종인플루엔자 대유행에 대한 백신 대응 전략
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최원석 | - |
dc.contributor.author | 김우주 | - |
dc.date.accessioned | 2021-09-08T23:15:24Z | - |
dc.date.available | 2021-09-08T23:15:24Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.issn | 2092-6448 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121519 | - |
dc.description.abstract | Four months have passed since the World Health Organization declared worldwide pandemic by the novel influenza A (H1N1) virus, but the incidence rate does not seem to dwindle and each day we are faced with news from all around the world on death by this troublesome virus. Pandemic influenza vaccine is considered one of the most effective countermeasures for protecting susceptible individuals. However, it is envisaged that production of sufficient vaccine within an ideal timeframe will not be feasible, and thus, vaccine supply is expected to fall short of demand. Therefore, it is mandatory to establish a proper vaccine strategy for maximizing the effect of pandemic influenza vaccine. In this article, we have described many critical points that should be taken into consideration when establishing pandemic vaccine strategies based on the newest data and the strategies adopted by other countries. | - |
dc.format.extent | 6 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한감염학회 | - |
dc.title | 신종인플루엔자 대유행에 대한 백신 대응 전략 | - |
dc.title.alternative | Vaccine Strategy for Influenza A (H1N1) Pandemic | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.41, no.5, pp 259 - 264 | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 41 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 259 | - |
dc.citation.endPage | 264 | - |
dc.identifier.kciid | ART001387741 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.subject.keywordAuthor | Influenza | - |
dc.subject.keywordAuthor | Vaccine | - |
dc.subject.keywordAuthor | Strategy | - |
dc.subject.keywordAuthor | Pandemic | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.